Use of artificial intelligence‐guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE‐echo trial
This randomized-controlled trial of AI-TTE will provide proof-of-concept for the role of AI-TTE in identifying pre-symptomatic HF or HVD when access to TTE is limited. Additionally, this could promote the usage of AI-TTE in rural or remote areas, ultimately improving health and quality of life of community dwelling adults with risks, signs or symptoms of cardiac dysfunction.
Authors
- Christopher Yu (ORCID: https://orcid.org/0000-0003-1025-5480)
- Leah Wright (ORCID: https://orcid.org/0000-0003-3269-6287)
- Cheng Hwee Soh (ORCID: https://orcid.org/0000-0001-8056-7354)
- Angus Baumann (ORCID: https://orcid.org/0000-0003-4128-7012)
- Bastian Seidel (ORCID: https://orcid.org/0000-0001-9404-9013)
- Thomas H. Marwick (ORCID: https://orcid.org/0000-0001-9065-0899)
- T. Mylius
- Mark Nolan (ORCID: https://orcid.org/0000-0003-1257-6982)
Institutions
- The University of Sydney (AU)
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- Nepean Hospital (AU)
- Walgett Aboriginal Medical Service (AU)
- WA Country Health Service (AU)
- Alice Springs Hospital (AU)
- Menzies Institute for Medical Research
Publication Details
- Journal
- American Heart Journal
- Published
- 2024-08-10
- DOI
- https://doi.org/10.1016/j.ahj.2024.08.004
- Citations
- 7
- Primary Topic
- Ultrasound in Clinical Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.95
Funders
- City Futures Research Centre
- National Health and Medical Research Council